logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Advanced melanoma: adding ziv-aflibercept to IL-2 boosts PFS

Phase 2 data support use of VEGF inhibitors to enhance IL-2 benefit.